Demetrix
Demetrix is a Berkeley-based biotechnology company founded in 2017 that researches and produces bioactive ingredients via fermentation-based synthetic biology. It is led by CEO Jeff Ubersax and co-founders Jay Keasling and William Haseltine, and has raised approximately $61M from biotech-oriented venture investors.
- Company typePrivate
- Founded2017
- HeadquartersBerkeley, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Demetrix firmographics
Firmographics- Name
- Demetrix
- Website
- https://demetrixbio.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 51–100 employees
- Short description
- Demetrix is a Berkeley-based biotechnology company founded in 2017 that researches and produces bioactive ingredients via fermentation-based synthetic biology. It is led by CEO Jeff Ubersax and co-founders Jay Keasling and William Haseltine, and has raised approximately $61M from biotech-oriented venture investors.
- Ownership category
- akta.pro rank
Demetrix industry classification
Industry- Product category
- Bioactive Ingredients
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
Keywords
Where Demetrix is headquartered
LocationHeadquarters
- HQ city
- Berkeley
- HQ country
- United States
- HQ region
- North America
Markets served
Demetrix business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
Demetrix product offering
Product offeringCore offering
Demetrix is a biotechnology company that researches and produces bioactive ingredients. The company applies biotechnology research and bioprocess development to manufacture bioactive ingredient products intended for downstream use by other businesses in applicable industries.
Differentiator
Problem solved
Functional benefit
Products and services
- Bioactive ingredients Bioactive ingredients researched and produced by Demetrix using biotechnology processes, intended for downstream business customers that incorporate such ingredients into formulated end products.
Companies that use Demetrix
Customer profileIdeal customer profiles1 record
Demetrix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Demetrix competitors and assessment
Company assessmentOthers
Direct peers
- Zymergen: Synthetic biology company combining automation and engineered microbes to develop bioproducts, also with Berkeley roots and similarly affected by the broader downturn in synthetic biology equities — a cautionary comparable for Demetrix's path.
- Conagen: Synthetic biology company that engineers microbes to produce high-value bioactive ingredients, including rare molecules and flavors/fragrances. Closely comparable to Demetrix in fermentation approach and bioactive ingredient output.
- Ginkgo Bioworks: Cell engineering and synthetic biology platform that programs organisms for ingredient and bioproduct applications. Comparable as a synthetic biology peer that similarly targeted ingredient and bioproduct customers via engineered organisms.
- Amyris: Fermentation-based ingredients company also founded by Jay Keasling out of UC Berkeley/JBEI; produces specialty ingredients via engineered yeast. Most direct comparable to Demetrix in technology, founder lineage, and ingredient focus, though broader in product scope.
Broad incumbents
- International Flavors & Fragrances (IFF): Major flavors, fragrances, and bioactive ingredients company with a Health & Biosciences division built partly through fermentation acquisitions. Represents the kind of strategic acquirer relevant to Demetrix's likely exit path.
- Novonesis (Novozymes): Global leader in industrial enzymes and microbial protein ingredients, serving food, beverage, and consumer health markets. Comparable as a broad incumbent in fermentation-derived bioactive ingredients that Demetrix's customers would also engage.
- DSM-Firmenich: Global nutrition, health, and flavors/fragrances group with active fermentation and synthetic biology sourcing programs. Comparable as a potential strategic acquirer for Demetrix-class bioactive ingredient platforms.
Emerging players
- Twist Bioscience: Synthetic biology company offering DNA synthesis and engineered biological tools, with adjacent efforts in biologic and ingredient discovery. Adjacent peer due to synthetic biology technology overlap with Demetrix's chassis/pathway engineering needs.
- LanzaTech: Gas fermentation company using engineered microbes to convert waste gases into fuels and chemicals, including ingredients. Comparable as a fermentation-based synthetic biology company producing novel ingredients at industrial scale.
Market position
Customer concentration
Demetrix social profiles
Digital presenceDemetrix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Demetrix leadership team
Management profileNumber of profiles
Profiles3 records
Demetrix funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Demetrix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Demetrix
What does Demetrix do?
Demetrix is a biotechnology company that researches and produces bioactive ingredients. The company applies biotechnology research and bioprocess development to manufacture bioactive ingredient products intended for downstream use by other businesses in applicable industries.
When was Demetrix founded?
Demetrix was founded in 2017. It employs 51 to 100 people.
Where is Demetrix based?
Demetrix is headquartered in Berkeley, United States, in the North America region.
Who are Demetrix's main competitors?
Codexis is listed as an others. Direct peers are Zymergen, Conagen, Ginkgo Bioworks and Amyris. Broad incumbents are International Flavors & Fragrances (IFF), Novonesis (Novozymes) and DSM-Firmenich. Emerging players are Twist Bioscience and LanzaTech.
Does Demetrix have an API?
No public API is recorded for Demetrix.
What industry is Demetrix in?
Demetrix's product category is Bioactive Ingredients. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 325414 and its SIC code is 2836.